Jason L. Cummings, Ph.D.
Affiliations: | 2013 | Sociology | Indiana University, Bloomington, Bloomington, IN, United States |
Area:
Social Structure and Development, Epidemiology, Public Health, Public and Social Welfare, Black Studies, African American StudiesGoogle:
"Jason Cummings"Cross-listing: PHTree
Parents
Sign in to add mentor| Jane D. McLeod | grad student | 2013 | Indiana University | |
| (Untangling racial and gender disparities in health and well-being in the United States, 1972--2008.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Dubois B, Villain N, Frisoni GB, et al. (2021) Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group. The Lancet. Neurology |
| Swanson CJ, Zhang Y, Dhadda S, et al. (2021) A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody. Alzheimer's Research & Therapy. 13: 80 |
| Scheltens P, De Strooper B, Kivipelto M, et al. (2021) Alzheimer's disease. Lancet (London, England) |
| Liss JL, Seleri Marques Assunção S, Cummings J, et al. (2021) Practical Recommendations for Timely, Accurate Diagnosis of Symptomatic Alzheimer's Disease (MCI and Dementia) in Primary Care: A Review and Synthesis. Journal of Internal Medicine |
| Cummings J. (2021) New approaches to symptomatic treatments for Alzheimer's disease. Molecular Neurodegeneration. 16: 2 |
| Cummings J. (2020) The Role of Neuropsychiatric Symptoms in Research Diagnostic Criteria for Neurodegenerative Diseases. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry |
| Cummings J, Lee G, Ritter A, et al. (2020) Alzheimer's disease drug development pipeline: 2020. Alzheimer's & Dementia (New York, N. Y.). 6: e12050 |
| Tariot P, Foff EP, Cummings JL, et al. (2020) HARMONY Study: Pimavanserin Significantly Prolongs Time to Relapse of Dementia-Related Psychosis Innovation in Aging. 4: 163-164 |
| Foff EP, Cummings JL, Soto-Martin M, et al. (2020) 427 - HARMONY study: pimavanserin significantly reduces risk of relapse of dementia-related psychosis International Psychogeriatrics. 32: 143-143 |
| Fischer CE, Ismail Z, Youakim JM, et al. (2019) Revisiting Criteria for Psychosis in Alzheimer's Disease and Related Dementias: Toward Better Phenotypic Classification and Biomarker Research. Journal of Alzheimer's Disease : Jad |